Henry Schein (HSIC) stock: analyst price target and their real reliability
Live quote · data updated Oct 14, 2026
Henry Schein · Health Care · ref. ETF XLV · 58 calls · price $85.03
What the company does: Henry Schein, Inc. provides health care products and services to office-based dental and medical practitioners worldwide.
📈 Henry Schein (HSIC) stock price
$85.03+34.1% over range
Oct 14, 25low $62.03 · high $90.86Oct 13, 26
📏 Click 2 points (left → right) to measure the change · click again to clear.
SellBuy
Hold
50% recommend buying · 8 analysts
📊 JPI status : Henry Schein has never appeared in a JPI ranking (Fair or Risk +) — our methods haven't picked it to date. See the selected stocks →
🎯 HSIC price target & analyst consensus — price $85.03
The price target · all analysts combined (8 targets)
Highest target · 1 firm of 8$112+31.7%
Median target · of 8 targets$94.5+11.1%
Lowest target · 1 firm of 8$64-24.7%
Current price$85.03
Where these 8 targets sit · versus the current price · 1 target per firm, last 6 months
Above the price
563%
$94 ↔ $112
Below
338%
$64 ↔ $85
⭐ What the most reliable analysts say
· those who beat their sector, targets replayed on real prices
⭐ The most reliable of them, either direction: Citigroup — 67% of its targets hit on this sector (516 calls tested). It aims for $112 (+32 %), call made on August 6, 2026, maturing on August 6, 2027 (69 d ago).
The 5 reliable analysts
$100+18 %
The 3 other firms
$82-3.6 %
How to read it: the 5 reliable firms are not filtered by optimism — 5 aim above the price, 0 below, hence their $100 median. “The 3 others” are the firms that don't pass our reliability filter on this sector.
The consensus · 8 ratings (last 6 months)
Strong Buy00%
Buy450%
Hold338%
Sell113%
Strong Sell00%
Go deeper on the analysts
🎯 HSIC price target all
All 58 calls, one by one, with our verdict on each firm.
→ See all 58 targets, analyst by analyst💡 The best analysts on HSIC most reliable
The case for and against, with the numbers, per those who've been right on the stock.
→ Should you invest in HSIC? The case for & againstAll analysts (the consensus) · vs · the best (those who've been right)
💬 A question about Henry Schein? The JPI assistant answers using our backtest data.
📈 Henry Schein fundamentals: valuation, margins & growth › open the full page
P/E 24.6Net margin 3.0 %Revenue growth +6.7 %Cheap for the growth
Revenue, net income and margin per year
Revenue Net income · hover a bar for details
2022
marg. 4 %
2023
Rev −2%Profit −23%
2024
Rev +3%Profit −6%
2025
Rev +4%Profit +2%
🏛️ Henry Schein insider buying: who's buying and how much › open the full page
1 insider bought1 buys / 6 mo $692k
🔎 Detailed analyses
🏛️ Which US Congress members hold Henry Schein (HSIC)?
1 Congress member has disclosed HSIC buys. Click a highlighted name to see their track record (do they beat the S&P 500?).
Thomas Suozzi 1× · 38%
✅ Historical analyst reliability on HSIC
Hit rate measured on targets already matured (12 months), replayed against real prices. Click a header to sort.
| Firm ↕ | % right i ↕ | Gain vs sector i ↕ | Calls i ↕ |
|---|---|---|---|
| Deutsche Bank ↗ | 100% | +18.4% | 2 |
| Stifel ↗ | 100% | +10.9% | 2 |
| Piper Sandler ↗ | 71% | +3.3% | 7 |
| Morgan Stanley ↗ | 71% | -2.1% | 7 |
| Evercore ISI Group ↗ | 67% | +5.7% | 3 |
| B of A Securities ↗ | 67% | -4.8% | 3 |
| JP Morgan ↗ | 50% | +9.6% | 4 |
| Barrington Research ↗ | 50% | +3.3% | 16 |
| Baird ↗ | 40% | +2.0% | 5 |
| Credit Suisse | 40% | -2.1% | 5 |
📊 What $1,000 invested in Henry Schein would be worth › open the full page
In short — $1,000 invested in Henry Schein 10 years ago would be worth $1,346 today, i.e. +3%/yr on average. Best year: 2021 (+16%), worst: 2024 (-9%). Price performance, excluding dividends.
If I'd invested $1,000 in Henry Schein
| Investment | Worth today | Gain |
|---|---|---|
| 1 years ago | $1,207 | +21% |
| 3 years ago | $1,046 | +5% |
| 5 years ago | $1,249 | +25% |
Return by year (Henry Schein)
| Year | Return | $1,000 invested at year start |
|---|---|---|
| 2026 (YTD) | +11% | $1,105 (+11%) |
| 2025 | +9% | $1,207 (+21%) |
| 2024 | -9% | $1,103 (+10%) |
⚠️ Past performance, not predictive nor advice. Prices in $, excluding dividends. Yahoo Finance data.
📰 Recent news on Henry Schein
Loading news…
📋 All analyst calls on HSIC
Filtered on — · ✕ show all
▲ Buy · 🎯$110
Price at call : $89.29 — upside +23%
Today : $85.03 — upside +29%
🎯 on HSIC : no call matured yet · 📊 on Health : 51.2% · +5.3% (123 calls)
in progress (365j)
matures : Aug 19, 27
matures : Aug 19, 27
▲ Overweight · 🎯$100
Price at call : $88.13 — upside +13%
Today : $85.03 — upside +18%
🎯 on HSIC : no call matured yet · 📊 on Health : 50.1% · +2.0% (645 calls)
in progress (365j)
matures : Aug 6, 27
matures : Aug 6, 27
■ Neutral neutral · not a buy · 🎯$94
Price at call : $88.23 — gap to target +7%
Today : $85.03 — gap to target +11%
🎯 on HSIC : no call matured yet · 📊 on Health : 51.7% · +3.1% (358 calls)
in progress (365j)
matures : Aug 5, 27
matures : Aug 5, 27
▲ Buy · 🎯$112
Price at call : $88.23 — upside +27%
Today : $85.03 — upside +32%
🎯 on HSIC : no call matured yet · 📊 on Health : 53.1% · +2.4% (516 calls)
in progress (365j)
matures : Aug 5, 27
matures : Aug 5, 27
▲ Buy · 🎯$100
Price at call : $89.59 — upside +12%
Today : $85.03 — upside +18%
🎯 on HSIC : no call matured yet · 📊 on Health : 51.2% · +5.3% (123 calls)
in progress (365j)
matures : Aug 5, 27
matures : Aug 5, 27
Piper Sandler ↗
Jul 29, 26
▲ Overweight · 🎯$95
Price at call : $85.17 — upside +12%
Today : $85.03 — upside +12%
🎯 on HSIC : 100% (1 call matured) · 📊 on Health : 46.6% · -1.4% (324 calls)
in progress (365j)
matures : Jul 29, 27
matures : Jul 29, 27
■ Neutral neutral · not a buy · 🎯$89
Price at call : $85.83 — gap to target +4%
Today : $85.03 — gap to target +5%
🎯 on HSIC : no call matured yet · 📊 on Health : 51.7% · +3.1% (358 calls)
in progress (365j)
matures : Jul 28, 27
matures : Jul 28, 27
BMO Capital ↗
Jul 9, 26
■ Market Perform neutral · not a buy · 🎯$85
Price at call : $84.4 — gap to target +1%
Today : $85.03 — gap to target -0%
🎯 on HSIC : no call matured yet · 📊 on Health : 60.4% · +8.8% (240 calls)
in progress (365j)
matures : Jul 9, 27
matures : Jul 9, 27
See the other 50 calls, newest to oldest
▲ Buy · 🎯$100
Price at call : $80.22 — upside +25%
Today : $85.03 — upside +18%
🎯 on HSIC : no call matured yet · 📊 on Health : 51.2% · +5.3% (123 calls)
in progress (365j)
matures : Jun 11, 27
matures : Jun 11, 27
■ Neutral neutral · not a buy · 🎯$85
Price at call : $70.5 — gap to target +21%
Today : $85.03 — gap to target -0%
🎯 on HSIC : no call matured yet · 📊 on Health : 51.7% · +3.1% (358 calls)
in progress (365j)
matures : May 6, 27
matures : May 6, 27
■ Neutral neutral · not a buy · 🎯$82
Price at call : $70.5 — gap to target +16%
Today : $85.03 — gap to target -4%
🎯 on HSIC : no call matured yet · 📊 on Health : 51.4% · +3.4% (222 calls)
in progress (365j)
matures : May 6, 27
matures : May 6, 27
Morgan Stanley ↗
Apr 24, 26
▼ Underweight · 🎯$64
Price at call : $77.2 — upside -17%
Today : $85.03 — upside -25%
🎯 on HSIC : no call matured yet · 📊 on Health : 51.6% · +5.2% (830 calls)
in progress (365j)
matures : Apr 24, 27
matures : Apr 24, 27
■ Neutral neutral · not a buy
🎯 on HSIC : no call matured yet · 📊 on Health : 51.2% · +5.3% (123 calls)
in progress (365j)
matures : Apr 16, 27
matures : Apr 16, 27
▲ Buy · 🎯$100
Price at call : $77.21 — upside +30%
Today : $85.03 — upside +18%
🎯 on HSIC : no call matured yet · 📊 on Health : 53.1% · +2.4% (516 calls)
in progress (365j)
matures : Apr 15, 27
matures : Apr 15, 27
Evercore ISI Group ↗
Apr 8, 26
▲ Outperform · 🎯$90
Price at call : $75.62 — upside +19%
Today : $85.03 — upside +6%
🎯 on HSIC : 100% (1 call matured) · 📊 on Health : 44.6% · -0.4% (186 calls)
in progress (365j)
matures : Apr 8, 27
matures : Apr 8, 27
Barrington Research ↗
Feb 25, 26
▲ Outperform · 🎯$97
Price at call : $81.47 — upside +19%
Today : $85.03 — upside +14%
🎯 on HSIC : 54% (13 calls matureds) · 📊 on Health : 50% · -9.1% (20 calls)
in progress (365j)
matures : Feb 25, 27
matures : Feb 25, 27
■ Neutral neutral · not a buy · 🎯$87
Price at call : $81.47 — gap to target +7%
Today : $85.03 — gap to target +2%
🎯 on HSIC : no call matured yet · 📊 on Health : 51.7% · +3.1% (358 calls)
in progress (365j)
matures : Feb 25, 27
matures : Feb 25, 27
▲ Overweight · 🎯$92
Price at call : $81.47 — upside +13%
Today : $85.03 — upside +8%
🎯 on HSIC : 100% (1 call matured) · 📊 on Health : 53.8% · +5.2% (364 calls)
in progress (365j)
matures : Feb 25, 27
matures : Feb 25, 27
■ Neutral neutral · not a buy · 🎯$88
Price at call : $81.47 — gap to target +8%
Today : $85.03 — gap to target +3%
🎯 on HSIC : no call matured yet · 📊 on Health : 51.4% · +3.4% (222 calls)
in progress (365j)
matures : Feb 25, 27
matures : Feb 25, 27
Morgan Stanley ↗
Feb 25, 26
▼ Underweight · 🎯$61
Price at call : $81.47 — upside -25%
Today : $85.03 — upside -28%
🎯 on HSIC : no call matured yet · 📊 on Health : 51.6% · +5.2% (830 calls)
in progress (365j)
matures : Feb 25, 27
matures : Feb 25, 27
Wells Fargo ↗
Feb 25, 26
■ Equal-Weight neutral · not a buy · 🎯$87
Price at call : $81.47 — gap to target +7%
Today : $85.03 — gap to target +2%
🎯 on HSIC : no call matured yet · 📊 on Health : 47.6% · +1.0% (403 calls)
in progress (365j)
matures : Feb 25, 27
matures : Feb 25, 27
Evercore ISI Group ↗
Feb 25, 26
▲ Outperform · 🎯$100
Price at call : $81.91 — upside +22%
Today : $85.03 — upside +18%
🎯 on HSIC : 100% (1 call matured) · 📊 on Health : 44.6% · -0.4% (186 calls)
in progress (365j)
matures : Feb 25, 27
matures : Feb 25, 27
Leerink Partners ↗
Feb 24, 26
■ Market Perform neutral · not a buy · 🎯$87
Price at call : $81.91 — gap to target +6%
Today : $85.03 — gap to target +2%
🎯 on HSIC : no call matured yet · 📊 on Health : 53.7% · -6.2% (41 calls)
in progress (365j)
matures : Feb 24, 27
matures : Feb 24, 27
▲ Outperform · 🎯$100
Price at call : $80.57 — upside +24%
Today : $85.03 — upside +18%
🎯 on HSIC : no call matured yet · 📊 on Health : 51.3% · +6.1% (302 calls)
in progress (365j)
matures : Feb 23, 27
matures : Feb 23, 27
■ Neutral neutral · not a buy · 🎯$81
Price at call : $77.73 — gap to target +4%
Today : $85.03 — gap to target -5%
🎯 on HSIC : no call matured yet · 📊 on Health : 51.4% · +3.4% (222 calls)
in progress (365j)
matures : Jan 20, 27
matures : Jan 20, 27
▲ Overweight · 🎯$86
Price at call : $75.88 — upside +13%
Today : $85.03 — upside +1%
🎯 on HSIC : no call matured yet · 📊 on Health : 50.1% · +2.0% (645 calls)
in progress (365j)
matures : Dec 9, 26
matures : Dec 9, 26
▲ Overweight · 🎯$78
Price at call : $70.06 — upside +11%
Today : $85.03 — upside -8%
🎯 on HSIC : 100% (1 call matured) · 📊 on Health : 53.8% · +5.2% (364 calls)
in progress (365j)
matures : Nov 5, 26
matures : Nov 5, 26
Barrington Research ↗
Nov 5, 25
▲ Outperform · 🎯$79
Price at call : $70.06 — upside +13%
Today : $85.03 — upside -7%
🎯 on HSIC : 54% (13 calls matureds) · 📊 on Health : 50% · -9.1% (20 calls)
in progress (365j)
matures : Nov 5, 26
matures : Nov 5, 26
Morgan Stanley ↗
Nov 5, 25
▼ Underweight · 🎯$58
Price at call : $70.06 — upside -17%
Today : $85.03 — upside -32%
🎯 on HSIC : no call matured yet · 📊 on Health : 51.6% · +5.2% (830 calls)
in progress (365j)
matures : Nov 5, 26
matures : Nov 5, 26
Wells Fargo ↗
Nov 5, 25
■ Equal-Weight neutral · not a buy · 🎯$76
Price at call : $70.06 — gap to target +8%
Today : $85.03 — gap to target -11%
🎯 on HSIC : no call matured yet · 📊 on Health : 47.6% · +1.0% (403 calls)
in progress (365j)
matures : Nov 5, 26
matures : Nov 5, 26
Evercore ISI Group ↗
Nov 5, 25
▲ Outperform · 🎯$90
Price at call : $72.01 — upside +25%
Today : $85.03 — upside +6%
🎯 on HSIC : 100% (1 call matured) · 📊 on Health : 44.6% · -0.4% (186 calls)
in progress (365j)
matures : Nov 5, 26
matures : Nov 5, 26
Barrington Research ↗
Oct 22, 25
▲ Outperform · 🎯$78
Price at call : $63.51 — upside +23%
Today : $85.03 — upside -8%
🎯 on HSIC : 54% (13 calls matureds) · 📊 on Health : 50% · -9.1% (20 calls)
in progress (365j)
matures : Oct 22, 26
matures : Oct 22, 26
Barrington Research ↗
Sep 23, 25
▲ Outperform · 🎯$78
Price at call : $67.75 — upside +15%
Today : $85.03 — upside -8%
Expected +15% · Actual +26% · Reason (≥ +15%) : ✓ Yes
🎯 on HSIC : 54% (13 calls matureds) · 📊 on Health : 50% · -9.1% (20 calls)
+26.2%
stock +26% · XLV +25%
matured Sep 23, 26
Evercore ISI Group ↗
Aug 26, 25
▲ Outperform · 🎯$83
Price at call : $69.06 — upside +20%
Today : $85.03 — upside -2%
Expected +20% · Actual +31% · Reason (≥ +15%) : ✓ Yes
🎯 on HSIC : 100% (1 call matured) · 📊 on Health : 44.6% · -0.4% (186 calls)
+30.9%
stock +31% · XLV +27%
matured Aug 26, 26
▲ Overweight · 🎯$76
Price at call : $65.94 — upside +15%
Today : $85.03 — upside -11%
Expected +15% · Actual +34% · Reason (≥ +15%) : ✓ Yes
🎯 on HSIC : 100% (1 call matured) · 📊 on Health : 53.8% · +5.2% (364 calls)
+33.6%
stock +34% · XLV +29%
matured Aug 7, 26
■ Neutral neutral · not a buy · 🎯$70
Price at call : $65.9 — gap to target +6%
Today : $85.03 — gap to target -18%
🎯 on HSIC : no call matured yet · 📊 on Health : 51.7% · +3.1% (358 calls)
in progress (365j)
matures : Aug 6, 26
matures : Aug 6, 26
Evercore ISI Group ↗
Aug 6, 25
■ In-Line neutral · not a buy · 🎯$70
Price at call : $65.9 — gap to target +6%
Today : $85.03 — gap to target -18%
🎯 on HSIC : 100% (1 call matured) · 📊 on Health : 44.6% · -0.4% (186 calls)
in progress (365j)
matures : Aug 6, 26
matures : Aug 6, 26
Barrington Research ↗
Aug 6, 25
▲ Outperform · 🎯$78
Price at call : $66.32 — upside +18%
Today : $85.03 — upside -8%
Expected +18% · Actual +33% · Reason (≥ +15%) : ✓ Yes
🎯 on HSIC : 54% (13 calls matureds) · 📊 on Health : 50% · -9.1% (20 calls)
+33.0%
stock +33% · XLV +26%
matured Aug 6, 26
■ Hold neutral · not a buy · 🎯$75
Price at call : $71.46 — gap to target +5%
Today : $85.03 — gap to target -12%
🎯 on HSIC : no call matured yet · 📊 on Health : 50.7% · +7.8% (304 calls)
in progress (365j)
matures : Jul 25, 26
matures : Jul 25, 26
■ Neutral neutral · not a buy · 🎯$72
Price at call : $70.68 — gap to target +2%
Today : $85.03 — gap to target -15%
🎯 on HSIC : no call matured yet · 📊 on Health : 51.3% · +6.1% (302 calls)
in progress (365j)
matures : Jul 14, 26
matures : Jul 14, 26
Evercore ISI Group ↗
Jul 9, 25
■ In-Line neutral · not a buy · 🎯$78
Price at call : $74.16 — gap to target +5%
Today : $85.03 — gap to target -8%
🎯 on HSIC : 100% (1 call matured) · 📊 on Health : 44.6% · -0.4% (186 calls)
in progress (365j)
matures : Jul 9, 26
matures : Jul 9, 26
Wells Fargo ↗
May 6, 25
■ Equal-Weight neutral · not a buy · 🎯$75
Price at call : $66.24 — gap to target +13%
Today : $85.03 — gap to target -12%
🎯 on HSIC : no call matured yet · 📊 on Health : 47.6% · +1.0% (403 calls)
in progress (365j)
matures : May 6, 26
matures : May 6, 26
Barrington Research ↗
May 6, 25
▲ Outperform · 🎯$86
Price at call : $66.24 — upside +30%
Today : $85.03 — upside +1%
Expected +30% · Actual +9% · Reason (≥ +15%) : ✗ No
🎯 on HSIC : 54% (13 calls matureds) · 📊 on Health : 50% · -9.1% (20 calls)
+9.4%
stock +9% · XLV +8%
matured May 6, 26
Piper Sandler ↗
Apr 30, 25
▲ Overweight · 🎯$77
Price at call : $64.46 — upside +19%
Today : $85.03 — upside -9%
Expected +19% · Actual +15% · Reason (≥ +15%) : ✗ No
🎯 on HSIC : 100% (1 call matured) · 📊 on Health : 46.6% · -1.4% (324 calls)
+14.7%
stock +15% · XLV +6%
matured Apr 30, 26
■ Neutral neutral · not a buy · 🎯$80
Price at call : $72.12 — gap to target +11%
Today : $85.03 — gap to target -6%
🎯 on HSIC : no call matured yet · 📊 on Health : 51.7% · +3.1% (358 calls)
in progress (365j)
matures : Feb 26, 26
matures : Feb 26, 26
Barrington Research ↗
Feb 26, 25
▲ Outperform · 🎯$90
Price at call : $72.55 — upside +24%
Today : $85.03 — upside +6%
Expected +24% · Actual +12% · Reason (≥ +15%) : ✗ No
🎯 on HSIC : 54% (13 calls matureds) · 📊 on Health : 50% · -9.1% (20 calls)
+12.3%
stock +12% · XLV +6%
matured Feb 26, 26
Wells Fargo ↗
Feb 14, 25
■ Equal-Weight neutral · not a buy · 🎯$80
Price at call : $76 — gap to target +5%
Today : $85.03 — gap to target -6%
🎯 on HSIC : no call matured yet · 📊 on Health : 47.6% · +1.0% (403 calls)
in progress (365j)
matures : Feb 14, 26
matures : Feb 14, 26
Barrington Research ↗
Jan 30, 25
▲ Outperform · 🎯$90
Price at call : $80.03 — upside +12%
Today : $85.03 — upside +6%
Expected +12% · Actual -6% · Reason (≥ +15%) : ✗ No
🎯 on HSIC : 54% (13 calls matureds) · 📊 on Health : 50% · -9.1% (20 calls)
-5.7%
stock -6% · XLV +5%
matured Jan 30, 26
■ Hold neutral · not a buy · 🎯$80
Price at call : $74.97 — gap to target +7%
Today : $85.03 — gap to target -6%
🎯 on HSIC : no call matured yet · 📊 on Health : 51.2% · +4.7% (383 calls)
in progress (365j)
matures : Jan 23, 26
matures : Jan 23, 26
B of A Securities ↗
Jan 6, 25
▲ Buy · 🎯$84
Price at call : $71.76 — upside +17%
Today : $85.03 — upside -1%
Expected +17% · Actual +9% · Reason (≥ +15%) : ✗ No
🎯 on HSIC : 100% (1 call matured) · 📊 on Health : 48.1% · +2.0% (362 calls)
+9.5%
stock +9% · XLV +14%
matured Jan 6, 26
Barrington Research ↗
Nov 6, 24
▲ Outperform · 🎯$82
Price at call : $69.43 — upside +18%
Today : $85.03 — upside -4%
Expected +18% · Actual +4% · Reason (≥ +15%) : ✗ No
🎯 on HSIC : 54% (13 calls matureds) · 📊 on Health : 50% · -9.1% (20 calls)
+3.6%
stock +4% · XLV -2%
matured Nov 6, 25
Barrington Research ↗
Sep 20, 24
▲ Outperform · 🎯$82
Price at call : $71.63 — upside +14%
Today : $85.03 — upside -4%
Expected +14% · Actual -5% · Reason (≥ +15%) : ✗ No
🎯 on HSIC : 54% (13 calls matureds) · 📊 on Health : 50% · -9.1% (20 calls)
-5.2%
stock -5% · XLV -12%
matured Sep 20, 25
Barrington Research ↗
Aug 7, 24
▲ Outperform · 🎯$82
Price at call : $65.77 — upside +25%
Today : $85.03 — upside -4%
Expected +25% · Actual +0% · Reason (≥ +15%) : ✗ No
🎯 on HSIC : 54% (13 calls matureds) · 📊 on Health : 50% · -9.1% (20 calls)
+0.2%
stock +0% · XLV -12%
matured Aug 7, 25
Barrington Research ↗
Jul 5, 24
▲ Outperform · 🎯$92
Price at call : $64.75 — upside +42%
Today : $85.03 — upside +8%
Expected +42% · Actual +13% · Reason (≥ +15%) : ✗ No
🎯 on HSIC : 54% (13 calls matureds) · 📊 on Health : 50% · -9.1% (20 calls)
+13.4%
stock +13% · XLV -7%
matured Jul 5, 25
Barrington Research ↗
May 8, 24
▲ Outperform · 🎯$92
Price at call : $73.44 — upside +25%
Today : $85.03 — upside +8%
Expected +25% · Actual -7% · Reason (≥ +15%) : ✗ No
🎯 on HSIC : 54% (13 calls matureds) · 📊 on Health : 50% · -9.1% (20 calls)
-6.5%
stock -7% · XLV -7%
matured May 8, 25
Barrington Research ↗
Feb 28, 24
▲ Outperform · 🎯$90
Price at call : $76.47 — upside +18%
Today : $85.03 — upside +6%
Expected +18% · Actual -6% · Reason (≥ +15%) : ✗ No
🎯 on HSIC : 54% (13 calls matureds) · 📊 on Health : 50% · -9.1% (20 calls)
-5.6%
stock -6% · XLV +3%
matured Feb 27, 25
Barrington Research ↗
Nov 14, 23
▲ Outperform · 🎯$82
Price at call : $67.59 — upside +21%
Today : $85.03 — upside -4%
Expected +21% · Actual -2% · Reason (≥ +15%) : ✗ No
🎯 on HSIC : 54% (13 calls matureds) · 📊 on Health : 50% · -9.1% (20 calls)
-1.6%
stock -2% · XLV +13%
matured Nov 13, 24
Barrington Research ↗
Aug 8, 23
▲ Outperform · 🎯$90
Price at call : $77.42 — upside +16%
Today : $85.03 — upside +6%
Expected +16% · Actual -12% · Reason (≥ +15%) : ✗ No
🎯 on HSIC : 54% (13 calls matureds) · 📊 on Health : 50% · -9.1% (20 calls)
-12.0%
stock -12% · XLV +11%
matured Aug 7, 24
Frequently asked questions
Should I buy Henry Schein stock?
This isn't buy advice. For Henry Schein, the analyst consensus is "Hold", with an average price target of $94.50 (+11% vs the current price). What matters is their past reliability on this stock: the most reliable one is right 100% of the time (2 calls tracked on Henry Schein). We show the numbers — you decide.
Is it too late to buy Henry Schein? How high can it go?
The most bullish analyst target on Henry Schein is $112 (+32% above today's price); the average is $94.50. That's the upside they see. Check how reliable those analysts have actually been on Henry Schein on our site before trusting it.
Is Henry Schein still a good buy?
The most useful "opinion" isn't an opinion — it's a track record: 11 analysts have a real record on Henry Schein, the best hitting 100% over 2 calls. Current consensus: "Hold". Make your call on data, not noise.
Should you invest in Henry Schein? The case for and against
The arguments for and against, one by one, from the numbers: why invest in HSIC (and why hesitate).
What has Henry Schein's past performance been?
Historical returns and a "how much if I had invested" calculator: HSIC performance & returns.
Are insiders buying HSIC stock?
Executives' and large holders' buys and sells, decoded: insider buying on HSIC.
BIIB 
VRTX 
REGN 
UNH 
EW 
SRPT 
VEEV 
BSX